TECHNESCAN HDP
Details
- Status
- Prescription
- First Approved
- 1981-02-18
- Routes
- INJECTION
- Dosage Forms
- INJECTABLE
TECHNESCAN HDP Approval History
What TECHNESCAN HDP Treats
1 indicationsTECHNESCAN HDP is approved for 1 conditions since its original approval in 1981. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Altered Osteogenesis
Drugs Similar to TECHNESCAN HDP
FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
TECHNESCAN HDP FDA Label Details
ProIndications & Usage
FDA Label (PDF)Technescan HDP, after radiolabeling with sodium pertechnetate Tc 99m, is indicated for skeletal imaging to demonstrate areas of altered osteogenesis in adult and pediatric patients.
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.